XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Operating Activities      
Net income $ 20,422 $ 11,655  
Items not requiring (providing) cash      
Provision for credit losses 367 8,600  
Depreciation and amortization 2,657 2,610  
Share based compensation 27 50  
Mortgage servicing rights income 23 (347)  
Mortgage servicing rights net impairment (236) 322 $ 4,500
Premium amortization on securities, net 2,224 1,997  
Gain on sale of investment securities (914) (339)  
Gain on sale of mortgage loans (5,296) (3,473)  
Proceeds from sales of loans 137,060 68,892  
Loans originated for sale (126,024) (67,576)  
Change in cash value life insurance (511) (554)  
Gain on sale of other real estate owned 0 (8)  
Net change in:      
Interest receivable 445 1,054  
Interest payable (940) (290)  
Other assets 9,223 6,068  
Other liabilities (5,156) (484)  
Net cash provided by operating activities 33,371 28,177  
Investing Activities      
Purchases of securities available for sale (230,708) (129,405)  
Proceeds from sales, maturities, calls and principal repayments of securities available for sale 76,869 71,395  
Proceeds from maturities of securities held to maturity 6,623 6,708  
Net change in interest earning time deposits 982 (784)  
Net change in loans 202,290 (68,685)  
Proceeds on the sale of OREO and repossessed assets 507 155  
Change in premises and equipment, net (1,118) (2,030)  
Death benefit on bank owned life insurance 0 233  
Repurchase of outstanding stock 0 (19,636)  
Net cash provided by (used in) investing activities 55,445 (142,049)  
Net change in:      
Deposits 190,683 (48,731)  
Borrowings 6,581 154,935  
Net change from issuance of stock (694) 552  
Net proceeds from issuance of subordinated notes 0 0  
Dividends paid on common stock (5,761) (5,257)  
Net cash provided by financing activities 190,809 101,499  
Net Change in Cash and Cash Equivalents 279,625 (12,373)  
Cash and Cash Equivalents, Beginning of Period 249,711 98,831 98,831
Cash and Cash Equivalents, End of Period $ 529,336 $ 86,458 $ 249,711